Intracellular anti-inflammatory effects via NF-kB inhibition outlast the plasma window
In the future, the companies that make breakthroughs in long-acting formulations, multi-target drugs, and oral drug development will be well-positioned to lead the GLP-1 market.
The Zepbound (tirzepatide) label similarly notes alopecia as an adverse reaction
MEDI0382, a GLP-1 and Glucagon Receptor Dual Agonist, in Obese or Overweight Patients With Type 2 Diabetes: A Randomised, Controlled, Double-Blind, Ascending Dose and Phase 2a Study
"We live in a society that prizes freedom of choice and expression, values material wealth and tolerates vast inequality," argues Chris Rojek, sociology professor at City St George's, University of London